Association of Proteins Modulating Immune Response and Insulin Clearance During Gestation with Antenatal Complications in Patients with Gestational or Type 2 Diabetes Mellitus.
Arthur T KopylovAnna L KayshevaOlga PapyshevaIveta GribovaGalina KotayschLubov KharitonovaTatiana MayatskayaAnna KrasheninnikovaSergey G MorozovPublished in: Cells (2020)
The combination of the measured markers may assist (AUC = 0.893 (CI 95%, 0.785-0.980) in establishing the clinical finding of the developing DF especially in patients with GDM who are at the highest risk of chronic insulin resistance.
Keyphrases
- glycemic control
- insulin resistance
- pregnant women
- immune response
- type diabetes
- weight gain
- adipose tissue
- metabolic syndrome
- preterm infants
- high fat diet
- risk factors
- signaling pathway
- polycystic ovary syndrome
- skeletal muscle
- dendritic cells
- toll like receptor
- body mass index
- cardiovascular risk factors
- pregnancy outcomes
- cardiovascular disease
- weight loss
- physical activity